Prescription Drugs - Tunisia

Tunisia

In Tunisia, the revenue in the Prescription Drugs market is estimated to reach US$319.20m in 2024.
It is anticipated that the revenue will experience an annual growth rate (CAGR 2024-2029) of 2.35%, leading to a market volume of US$358.50m by 2029.
When compared globally, United States is expected to generate the highest revenue in the Prescription Drugs market, amounting to US$358.90bn in 2024.
In terms of per capita figures, each person in Tunisia is projected to generate revenues of US$25.41 in 2024.
Tunisia's prescription drug market is experiencing a surge in demand for generic drugs due to their affordability and accessibility.

Key regions: Japan, China, Europe, Australia, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Tunisia is experiencing significant growth and development.

Customer preferences: Customers in Tunisia are increasingly seeking convenience and accessibility when it comes to purchasing prescription drugs. As a result, there has been a growing demand for pharmacies that offer extended operating hours and multiple locations. This trend is driven by the busy lifestyles of consumers who are looking for quick and easy access to the medications they need.

Trends in the market: One of the key trends in the Prescription Drugs (Pharmacies) market in Tunisia is the increasing use of technology. Pharmacies are adopting digital solutions to streamline their operations and improve customer experience. Online platforms and mobile applications are being used to offer services such as online ordering and home delivery of prescription drugs. This trend is driven by the desire to provide convenience to customers and compete with online pharmacies. Another trend in the market is the growing focus on preventive healthcare. Pharmacies in Tunisia are expanding their product offerings to include a range of over-the-counter medications and health supplements. This trend is driven by the increasing awareness among consumers about the importance of maintaining good health and preventing diseases. Pharmacies are positioning themselves as one-stop shops for all healthcare needs, catering to both prescription and non-prescription medications.

Local special circumstances: Tunisia has a well-established healthcare system with a high level of government support. The government has implemented policies to ensure the availability and affordability of prescription drugs. This has created a favorable environment for the growth of the Prescription Drugs (Pharmacies) market in Tunisia. Additionally, the country has a large population with a high prevalence of chronic diseases, which further drives the demand for prescription drugs.

Underlying macroeconomic factors: The growing Prescription Drugs (Pharmacies) market in Tunisia is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income and healthcare spending. As a result, consumers have more purchasing power and are willing to spend on prescription drugs. Furthermore, the government has been investing in the healthcare sector, which has led to improved access to healthcare services and increased demand for prescription drugs. In conclusion, the Prescription Drugs (Pharmacies) market in Tunisia is witnessing significant growth and development. Customer preferences for convenience and accessibility, along with the adoption of technology, are driving the market. The focus on preventive healthcare and the favorable local circumstances, such as government support and a large population with chronic diseases, further contribute to the market's growth. The underlying macroeconomic factors, including economic growth and government investment in healthcare, also play a crucial role in shaping the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.